Deglutition Disorders clinical trials at UCSF
1 research study open to eligible people
Difficulty with swallowing is a disorder that makes it hard to eat and drink. There is a clinical trial at UCSF called "Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia." This trial will test the safety of AMDC-GIR and see if it can help people with swallowing difficulties. The trial is double-blind, randomized, and multicenter.
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
open to eligible people ages 18 years and up
The primary objective of this double-blind, randomized, placebo-controlled, multicenter clinical trial is to evaluate the safety of AMDC-GIR during the 24 months following 2 consecutive treatments of tongue dysphagia in male and female patients who have undergone surgery and/or chemo- and/or radiotherapy for squamous cell cancer of the oropharynx.
San Francisco, California and other locations
Our lead scientists for Deglutition Disorders research studies include Clark Rosen, MD.
Last updated: